We have designed a streptavidin-metallothionein chimeric protein in which the streptavidin moiety provides a means ofbinding the metallothionein moiety tightly to specific biological targets. A gene fusion of streptavidin with mouse metallothionein I was efficiently expressed in Escherichia coli, and the expressed chimeric protein was purified to homogeneity by a simple procedure. Metallothionein is a small cysteine-rich protein that is found in a broad range of eukaryotic species and in many different tissues (1, 2). This protein binds a variety of heavy metal ions with extremely high affinity through coordination bonds to its cysteine residues (1, 2). The heavy metals that can be bound by metallothionein include Cd, Zn, Cu, Hg, Co, Pb, Ni, Fe, Bi, Sn, Tc, Au, and Ag (2). Since various sensitive detection methods are available for heavy metals, such as x-ray fluorometry, polarography, atomic absorption spectrometry, mass spectrometry, anodic stripping voltammetry, inductively coupled plasma emission spectrometry, and NMR (3-9), as well as for various radioisotope species, bound heavy metal ions to metallothionein should be detected with high sensitivity by such methods. Many useful assay systems for specific biological targets could be developed if there were a way to attach metallothionein specifically to these targets. To provide metallothionein with the potential for labeling or conjugating biological materials with various heavy metal ions and their isotopes, we have designed a streptavidin-metallothionein chimeric protein.
metallothionein I was efficiently expressed in Escherichia coli, and the expressed chimeric protein was purified to homogeneity by a simple procedure. The purified chimera, consisting of four identical subunits, bound one biotin and approximately seven Cd21 ions per subunit (19.5 kDa) . This indicates that both the streptavidin and the metallothionein moieties are fully functional. The high binding affinity of the chimera both for biotin and for heavy metal ions allows the specific labeling or conjugation of any biological material containing unhindered biotin with a variety of different heavy metal ions and their isotopes, thereby opening the way for simultaneous assay systems for a large number of biological targets.
to the protein A moiety with recognition capability in addition to their natural antigen recognition-i.e., binding to biotin, biotin derivatives, and biotinylated biological materials. This work showed that streptavidin-containing chimeric proteins are capable of retaining both the biotin-binding activity of the streptavidin and the ligand-binding activity of the proteins fused to it.
Here we describe the design and expression of a streptavidin-metallothionein chimeric protein. We have expressed the chimera in E. coli and purified it to homogeneity. The purified chimera was able to label biological materials containing unhindered biotin specifically with heavy metal ions. These results imply that the chimera has the potential to serve as a tool for tagging a wide variety of biological materials with many different heavy metal ions and their isotopes.
Metallothionein is a small cysteine-rich protein that is found in a broad range of eukaryotic species and in many different tissues (1, 2) . This protein binds a variety of heavy metal ions with extremely high affinity through coordination bonds to its cysteine residues (1, 2) . The heavy metals that can be bound by metallothionein include Cd, Zn, Cu, Hg, Co, Pb, Ni, Fe, Bi, Sn, Tc, Au, and Ag (2) . Since various sensitive detection methods are available for heavy metals, such as x-ray fluorometry, polarography, atomic absorption spectrometry, mass spectrometry, anodic stripping voltammetry, inductively coupled plasma emission spectrometry, and NMR (3-9), as well as for various radioisotope species, bound heavy metal ions to metallothionein should be detected with high sensitivity by such methods. Many useful assay systems for specific biological targets could be developed if there were a way to attach metallothionein specifically to these targets. To provide metallothionein with the potential for labeling or conjugating biological materials with various heavy metal ions and their isotopes, we have designed a streptavidin-metallothionein chimeric protein.
Streptavidin, a protein produced by Streptomyces avidinii, specifically binds the water-soluble vitamin D-biotin with remarkably high affinity (10) (11) (12) . The tight and specific binding affinity of streptavidin for biotin and the potential ability of biotin to be easily incorporated into various biological materials have made the streptavidin-biotin system a useful tool for detection and characterization of such materials (13) (14) (15) (16) (17) (18) . We have developed an expression system for the cloned streptavidin gene, which efficiently produces streptavidin in Escherichia coli (19) . The establishment ofthe expression system allowed the design and preparation of streptavidin-containing chimeric proteins. More recently, we have designed a streptavidin-protein A chimera (20) (19, 20, 22) . Lysogen BL21(DE3)(pLysE) (23, 24) carrying the expression vector pTSAMT-2 was grown at 370C with shaking in M9 minimal medium (25) (23, 24) and the Tct transcription terminator (23 Purification of a Streptavidin-Metailothionein Chimeric Protein. Purification of the expressed streptavidin-metallothionein chimeric protein was carried out at 40C or on ice, unless otherwise stated. We used BL21(DE3)(pLysE)(pTSAMT-2) incubated for 5 hr after induction as the source. The culture (100 ml) was centrifuged at 2900 x g for 10 min, and the cell pellet was suspended in 10 ml of 2 mM EDTA/30 mM Tris Cl, pH 8.0/0.1% Triton X-100/10 mM dithiothreitol (DTT)/0.1 mM phenylmethylsulfonyl fluoride (PMSF) to lyse the cells. The cell lysate was stored frozen at -70°C until used.
To the thawed cell lysate (10 ml), PMSF, pepstatin A, and leupeptin were added to final concentrations of 1 mM, 1 ,uM, and 1 ,uM, respectively. The addition of the proteinase inhibitors was indispensable to prevent proteolysis of the expressed chimera during purification. The cell lysate was then treated with DNase I (10 pgg/ml) and RNase A (10 pug/ml) in the presence of 12 mM MgSO4 at room temperature (=20°C) for 30 min, followed by centrifugation at 39,000 x g for 15 min. The precipitate was dissolved in 5 ml of 6 M guanidine hydrochloride, pH 1.5/10 mM DTT and dialyzed against the same solution to remove bound biotin. To reduce the protein concentration, the dialyzed sample was diluted with the same solution to a total volume of =100 ml and then dialyzed against 0.2 M ammonium acetate, pH 6.0/0.5 mM CdCl2/0.1 mM EDTA/1 mM PMSF/1 ,uM pepstatin A/1 ,uM leupeptin/0.02% NaN3. To achieve slow removal of guanidine hydrochloride, the dialysis bag containing the diluted sample was left overnight in the solution (=800 ml) without stirring, followed by several changes of the dialysis solution and dialysis with stirring. The dialyzed fraction was centrifuged at 39,000 x g for 15 min, and the supernatant was briefly dialyzed against 1.0 M NaCl/50 mM sodium carbonate, pH 10 The x-ray fluorescence analysis system was described previously (28 (21) into the polylinker of an expression vector for streptavidin-containing chimeric proteins, pTSA-18F (22) . The resulting expression vector pTSAMT-2 ( Fig. 1 ) encodes a streptavidin-metallothionein chimeric protein (19.5 kDa), in which the metallothionein moiety follows the core region of streptavidin. The encoded chimera, consisting of 190 amino acid residues, contains 20 cysteine residues, which are derived solely from the metallothionein moiety.
To express the gene fusion of streptavidin with metallothionein, we used the T7 expression system (23), with which we had previously successfully expressed a cloned streptavidin gene in E. coli (19) . SDS/PAGE of the total cell protein during expression ( Fig. 2A) showed a major band at 22 kDa after the induction of the T7 RNA polymerase gene. The apparent molecular mass of the major band was higher than that estimated from the deduced amino acid sequence (19.5 kDa were pulse-labeled with [35S]cysteine during expression. Because of the high cysteine content, the metallothionein moiety of the expressed chimera should be strongly labeled with radioactive cysteine. Autoradiography of the gel (Fig. 2B) showed that the [35Slcysteine was incorporated almost exclusively into the 22-kDa protein. This result reveals that the 22-kDa protein is cysteine-rich and indicates that it is the streptavidin-metallothionein chimeric protein. The discrepancy in the molecular masses of the chimera estimated by SDS/PAGE and from the deduced amino acid sequence will be discussed below.
Expression of the chimeric protein in minimal medium had the advantage that proteolysis ofthe expressed chimera in the host cells was considerably reduced. When LB medium (25) was used, instead, a major smeared band appeared at around 19 kDa, and no intact chimera was observed on SDS/PAGE. E. coli BL21(DE3)(pLysE) expressed the chimera more efficiently than the equivalent strain carrying pLysS (23) .
Purification and Characterization of a StreptavidinMetaflothionein Chimeric Protein. The expressed streptavidin-metallothionein chimeric protein was purified to homogeneity (Fig. 3A) by a simple purification procedure including affinity chromatography using 2-iminobiotin as the ligand. After complete denaturation ofthe expressed chimera, which formed inclusion bodies in the cells, renaturation in the presence of heavy metal ions such as Cd2+ and Zn2+ provided the chimera with additional stability, which allowed frozen storage and lyophilization. By this procedure, the yield ofthe purified chimera ranged from 0.8 to 1.2 mg per 100 ml of culture.
In addition to monomer, the subunit dimer and tetramer were also observed on SDS/PAGE (Fig. 3A) , though the protein sample was heated in boiling water for 5 min in the presence of 3% SDS and 10 mM DlT. Although natural streptavidin shows subunit oligomers on SDS/PAGE (30) (31) (32) (33) , the amounts of such molecules for the chimera seem greater than those for natural streptavidin. It is not clear, however, why the subunit association of the chimera in the presence of SDS is tighter than that of natural streptavidin. It is possible that intersubunit disulfide bonds, which are not completely cleavable even by DTT, are associated with the subunit oligomer formation. The streptavidin-metallothionein chimeric protein containing "U0Cd2 was also subjected to SDS/PAGE. Autoradiography of the gel (Fig. 3B) indicated that the chimera retained the bound heavy metal ions even after the heat treatment indicated above. This result demonstrates the extreme stability of the chimera-heavy metal ion complexes. The higher apparent molecular mass of the chimera on SDS/PAGE can be explained by the presence of the bound heavy metal ions, which provide the chimera with additional positive charges resulting in slower migration.
The purified streptavidin-metallothionein chimeric protein bound 0.99 molecule of biotin per subunit (19.5 kDa), indicating that the chimera had full biotin-binding ability. In addition, the purified chimera bound 6.7 ± 1.0 Cd2+ ions per subunit, as determined by quantitative x-ray fluorescence analysis. Since mammalian metallothioneins bind a maximum of seven Cd2+ ions per molecule (1, 2, (34) (35) (36) , this result indicates that the metallothionein moiety of the chimera is also fully functional.
On gel filtration chromatography (Fig. 4) , the molecular mass of the chimeric protein under nondenaturing conditions was estimated to be -85 kDa, indicating that the chimera forms a subunit tetramer. This result also reveals that the subunit association of the chimera is determined by the streptavidin moiety. Therefore, one streptavidin-metallothionein chimera consisting of four subunits binds four biotin molecules and 28 Cd2+ ions. Although aggregation of the chimera was observed when frozen-stored samples were used, the amount of such aggregates was <15% of the total protein. However, such aggregated molecules also retained biotin-binding ability.
Targeting toradiography of the membrane (Fig. SA) showed that the biotinylated peroxidase was specifically labeled with '19Cd2+. This result clearly indicates that the bound heavy metal ions of the metallothionein moiety of the chimera were specifically attached to the biotinylated peroxidase by the chimera (Fig. 5B) . The result also documents that the chimera can bind biotin and heavy metal ions simultaneously. Since extensive washing steps were included in this system, the result indicates that the chimera retains the tight binding affinity both for biotin and for heavy metal ions that the natural streptavidin and metallothionein molecules possess. This is also supported by absence ofa background signal from nonspecific binding of the chimera or the bound 109Cd2+ to the blocker molecules (gelatin).
In conclusion, the streptavidin-metallothionein chimeric protein is capable of labeling or conjugating biological materials containing unhindered biotin with various heavy metal ions and their isotopes. The potential ability of biotin to be incorporated easily into various biological materials, including proteins, nucleic acids, carbohydrates, lipids, cells, and tissues (17, 18) , will allow the application of this chimera to a broad range of biological materials. Such applications include multiple simultaneous labeling of various biological materials with different heavy metal ions or their isotopes, because the binding affinity of this chimera both for biotin and for heavy metal ions is extremely tight, so that exchange reactions should be prevented.
There are -50 species of heavy metal stable isotopes that can be bound by metallothionein. Thus, the streptavidinmetallothionein chimeric protein offers the potential of simultaneous multi-mass labeling of a mixture of many different biological materials, each with a different metal isotope. In principle, each of such labeled biological targets can be detected and distinguished from the others by mass spectrometry, which discriminates among the tagged metal isotopes. The abundance of the metal stable isotopes that can be bound by the chimera should substantially increase the number of labels that can be attached to different biological Proc. Nat. Acad. Sci. USA 89 (1992) targets. In addition, resonance ionization spectroscopy coupled with mass spectrometry (37-40) allows accurate detection and discrimination of such heavy metal isotopes down to a subattomole level. This means that a biotinylated biological target should be detectable with extremely high sensitivity upon binding the chimeric protein, each molecule of which can attach many heavy metal ions to the target.
